CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Aug. 31, 2011	Nov. 30, 2010
ASSETS
Cash and cash equivalents	$ 667,299	$ 634,377
Grant receivable	303,102	30,975
Other current assets	9,894	8,931
Total current assets	980,295	674,283
Property and equipment, net of accumulated depreciation of $66,398 and $65,380 at August 31, 2011 and November 30, 2010, respectively	69	1,087
Other assets	1,685	1,685
Total assets	982,049	677,055
LIABILITIES AND EQUITY (DEFICIENCY)
Accounts payable and accrued expenses	1,440,845	1,677,001
Advance from debenture holder	436,000	237,850
Current portion of deferred revenue	49,318	49,318
Total current liabilities	1,926,163	1,964,169
Non-current liabilities
Convertible debentures, net of discount	56,056	50,706
Deferred income, net of current portion	560,388	597,376
Derivative liability related to Series B convertible preferred stock	255,716	79,913
Total non-current liabilities	872,160	727,995
Total liabilities	2,798,323	2,692,164
Commitments and contingencies	0	0
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock value	0	0
Common stock, $0.01 par value; 1,250,000,000 shares authorized; 785,463,128 and 476,746,257 shares issued and outstanding at August 31, 2011 and November 30, 2010, respectively	7,854,631	4,767,463
Additional paid-in capital	30,115,978	31,317,428
Accumulated deficit	(40,795,387)	(39,197,686)
Total MultiCell Technologies, Inc. stockholders' equity (deficiency)	(901,534)	(1,189,551)
Noncontrolling interests	(914,740)	(825,558)
Total equity (deficiency)	(1,816,274)	(2,015,109)
Total liabilities and equity (deficiency)	982,049	677,055
Series B Convertible Preferred Stock [Member]
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock value	1,349,844	1,349,844
Series I Convertible Preferred Stock [Member]
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock value	$ 573,400	$ 573,400